Josep Arnau

627 total citations
14 papers, 446 citations indexed

About

Josep Arnau is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Josep Arnau has authored 14 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Josep Arnau's work include Cardiac electrophysiology and arrhythmias (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Blood Pressure and Hypertension Studies (2 papers). Josep Arnau is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Blood Pressure and Hypertension Studies (2 papers). Josep Arnau collaborates with scholars based in Spain, Sweden and Italy. Josep Arnau's co-authors include Enrique Galve, Jordi Soler‐Soler, David García‐Dorado, Teresa Rius, Antonio Vallano, Xavier Vidal, Antònia Agustí, A.M. López, Ferrán Pellisé and Núria Prat and has published in prestigious journals such as Journal of the American College of Cardiology, European Spine Journal and Drug Safety.

In The Last Decade

Josep Arnau

13 papers receiving 412 citations

Peers

Josep Arnau

CCM

PHARM

TOXIC

EE

PHEOH

R Herings Netherlands

E. Pérez Spain

Ljubica Vukelic Andersen Denmark

Feng-Hwa Lu Taiwan

Joseph Couto United States

Alexander J. Lawson United Kingdom

Eva‐Maria Fronk Germany

Luis Carlos Saiz Spain

C. Dureau‐Pournin France

Leila Chebane France

R Herings Netherlands

Josep Arnau

163 ×0.7

CCM

96 ×1.2

PHARM

18 ×0.3

TOXIC

24 ×0.5

EE

42 ×1.1

PHEOH

Citations per year, relative to Josep Arnau Josep Arnau (= 1×) peers R Herings

Countries citing papers authored by Josep Arnau

Since Specialization

Citations

This map shows the geographic impact of Josep Arnau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Arnau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Arnau more than expected).

Fields of papers citing papers by Josep Arnau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Arnau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Arnau. The network helps show where Josep Arnau may publish in the future.

Co-authorship network of co-authors of Josep Arnau

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Arnau. A scholar is included among the top collaborators of Josep Arnau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Arnau. Josep Arnau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Ciruela, Francisco, Antonio Vallano, Lourdes Carbonell, et al.. (2014). Deciphering G Protein-Coupled Receptor Biology with Fluorescence-based Methods. Current Pharmaceutical Biotechnology. 15(10). 962–970. 1 indexed citations

2.

Ciruela, Francisco, Antonio Vallano, Josep Arnau, et al.. (2010). G protein-coupled receptor oligomerization for what?. Journal of Receptors and Signal Transduction. 30(5). 322–330. 16 indexed citations

3.

Pedrós, Consuelo, Antonio Vallano, Antònia Agustí, et al.. (2009). An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians. Drug Safety. 32(1). 77–83. 70 indexed citations

4.

Arnau, Josep, et al.. (2009). Tratamiento de la hipertensión en pacientes mayores de 80 años. Revista Española de Geriatría y Gerontología. 44(3). 162–164. 2 indexed citations

5.

Roig, Jorge, Josep Arnau, Antonio Vallano, & Jordi Rello. (2007). New Developments in Therapeutic Agents for Legionnaires Disease. 6(4). 228–242. 2 indexed citations

6.

Arnau, Josep, et al.. (2005). A critical review of guidelines for low back pain treatment. European Spine Journal. 15(5). 543–553. 84 indexed citations

7.

Bonet, Sergi, et al.. (2003). Adverse Effects of ACE Inhibitors in Patients with Chronic Heart Failure and/or Ventricular Dysfunction. Drug Safety. 26(12). 895–908. 16 indexed citations

8.

Arnau, Josep, et al.. (2002). L'educació médica basada en l'evidéncia: La Col•laboració BEME/EMBE. 85(4). 192–195. 1 indexed citations

9.

Agustí, Antònia & Josep Arnau. (2002). Tratamiento del infarto agudo de miocardio con los nuevos fármacos trombolíticos. Medicina Clínica. 119(7). 273–275. 1 indexed citations

10.

Danés, Imma & Josep Arnau. (2001). ¿Es segura la administración de quinolonas en la edad pediátrica?. Medicina Clínica. 117(17). 676–677.

11.

Arnau, Josep, et al.. (2000). El consentiment informat i el respecte a l'autonomia del malalt. 83(2). 106–108. 2 indexed citations

12.

Bonet, Sergi, Antònia Agustí, Josep Arnau, et al.. (2000). β-Adrenergic Blocking Agents in Heart Failure. Archives of Internal Medicine. 160(5). 621–7. 68 indexed citations

13.

Galve, Enrique, et al.. (1996). Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study. Journal of the American College of Cardiology. 27(5). 1079–1082. 182 indexed citations

14.

Rodríguez, C.A., Josep Arnau, R. Jódar, et al.. (1989). Evaluation of Cefonicid Use in a General Hospital. DICP. 23(2). 154–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact